What Caught Our Attention in the Investment World? – Week of June 7-11, 2021
By Kuldip K. Ambastha Biogen Inc. (BIIB), a biotech company, had a memorable Monday of this past trading week. On Monday, June 7, 2021, Biogen had a +38.3% gain for the day on its stock. Biogen’s Alzheimer’s disease treatment was approved by the U.S. Food and Drug Administration (FDA) as part of an accelerated approval …
Continue reading “What Caught Our Attention in the Investment World? – Week of June 7-11, 2021”